Consensus interferon for earlier non-responder or relapser patients with chronic hepatitis C.

被引：0
|
作者：
Karasu, Z [1 ]
Gurakar, A [1 ]
Jazzar, A [1 ]
Emmett, C [1 ]
Hulagu, S [1 ]
Wright, H [1 ]
机构：
[1] Baptist Med Ctr, Oklahoma Transplantat Inst, Oklahoma City, OK 73112 USA
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1874
引用
收藏
页码：629A / 629A
页数：1
相关论文
共 50 条
  • [31] Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C
    Fontana, Robert J.
    Dienstag, Jules L.
    Bonkovsky, Herbert L.
    Sterling, Richard K.
    Naishadham, Deepa
    Goodman, Zachary D.
    Lok, Anna S. F.
    Wright, Elizabeth C.
    Su, Grace L.
    GUT, 2010, 59 (10) : 1401 - 1409
  • [32] Low dose ribavirin (RBV) in combination interferon (IFN) for the treatment of hepatitis C non-responder and relapse patients
    Bernstein, DE
    Jeffers, LJ
    Lake-Bakaar, G
    Reddy, KR
    Schiff, ER
    GASTROENTEROLOGY, 1999, 116 (04) : A1190 - A1190
  • [33] Successful treatment of activated occult hepatitis B in a non-responder chronic hepatitis C patient
    Mohamed H Emara
    Mohamed I Radwan
    Virology Journal, 8
  • [34] Interferon alpha plus ketoprofen or interferon alpha plus ribavirin in chronic hepatitis C non-responder to interferon alpha alone: results of a pilot study
    Andreone, P
    Cursaro, C
    Gramenzi, A
    Fiorino, S
    Di Ciammarino, L
    Miniero, R
    D'Errico, A
    Grigioni, WF
    Gasbarrini, G
    Bernardi, M
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 31 (08): : 688 - 694
  • [35] Cost effectiveness of retreatment with consensus interferon for chronic hepatitis C.
    McHutchison, JG
    Woolley, JM
    Nyberg, LM
    HEPATOLOGY, 1997, 26 (04) : 1171 - 1171
  • [36] Cyclic and periodic interferon treatment repeated with interferon beta induction plus interferon alpha maintenance as a novel approach for interferon non-responder chronic hepatitis C patients with breakthrough.
    Kishida, Y
    Naitoh, M
    Katayama, K
    Itoh, M
    Egawa, S
    Kashiwagi, T
    Hayashi, N
    HEPATOLOGY, 2001, 34 (04) : 592A - 592A
  • [37] INTERFERON AS AN ADJUVANT FOR HEPATITIS-B VACCINATION IN NON-RESPONDER AND LOW-RESPONDER POPULATIONS
    GROB, PJ
    JOLLERJEMELKA, HI
    BINSWANGER, U
    ZARUBA, K
    DESCOEUDRES, C
    FERNEX, M
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1984, 3 (03) : 195 - 198
  • [38] Retreatment for chronic hepatitis C of interferon non-responder patients.: Preliminary results of a multicenter randomized controlled trial of interferon plus ribavirin versus interferon alone.
    de Lédinghen, V
    Bernard, PH
    Trimoulet, P
    Bourlière, M
    Portal, I
    Rémy, AJ
    Szostak, N
    Longo, F
    Thiefin, G
    Abergel, A
    Dumas, F
    Lucidarme, D
    Blanc, P
    Zylberberg, H
    Capron, D
    Doll, J
    Fleury, H
    Couzigou, P
    HEPATOLOGY, 1998, 28 (04) : 374A - 374A
  • [39] Retreatment of IFN/ribavirin non-responder hepatitis C patients: Benefit of PEG-interferon/ribavirin amantadine.
    Maynard, M
    Ahmed, SNS
    Bailly, F
    Rozier, F
    Benmakhlouf, N
    Bourne-Branchu, V
    Fazly, T
    Nemoz, C
    Adeleine, P
    Pradat, P
    Trepo, C
    HEPATOLOGY, 2004, 40 (04) : 398A - 398A
  • [40] Interferon retreatment of patients with chronic hepatitis C.
    Picciotto, A
    Campo, N
    Brizzolara, R
    Sinelli, N
    GiudiciCipriani, A
    Ponassi, I
    Varagona, G
    Grasso, A
    DeLeo, P
    DeConca, V
    Mesiti, S
    Marenco, G
    Menardo, G
    Dodero, M
    Celle, G
    HEPATOLOGY, 1997, 26 (04) : 1160 - 1160
12345